drugset / Trial / NCT00257712

SMART: Somatotrophics, Memory, and Aging Research Trial

NCT00257712 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of the SMART study was to better understand whether the body's own production of growth hormone (GH) would improve memory and problem solving ability, or cognitive function. The study was a double blind, placebo-controlled study of the cognitive effects of growth hormone releasing hormone (GHRH) in healthy older men and women and in those with mild cognitive impairment (MCI).

Timeline

Start
2006-02
Primary completion
2011-12
Completion
2011-12

Outcome

Met primary endpoint

paper The intent-to-treat analysis indicated a favorable effect of GHRH on cognition (P=.03), which was comparable in adults with MCI and healthy older adults. PMID 22869065 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Tesamorelin Peptide 1 mg Subcutaneous